Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)

EPS in 2026 (TTM): NZ-$0.01178

According to Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s latest financial reports the company's current EPS (TTM) is NZ-$0.01211. In 2025 the company made an earnings per share (EPS) of NZ-$0.09528 a decrease over its 2024 EPS that were of NZ-$0.06323.

EPS history for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from 2008 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	NZ-$0.01178	-87.64%
2025	NZ-$0.09528	50.68%
2024	NZ-$0.06323	-80.63%
2023	NZ-$0.33	-6686.04%
2022	NZ$0.004956	-92.61%
2021	NZ$0.06706	-5.23%
2020	NZ$0.07076	20.49%
2019	NZ$0.05872	57.51%
2018	NZ$0.03728	-32.43%
2017	NZ$0.05517	12.07%
2016	NZ$0.04923	3.71%
2015	NZ$0.04747	10.55%
2014	NZ$0.04294	12.16%
2013	NZ$0.03828	16.38%
2012	NZ$0.03290	18.34%
2011	NZ$0.02780	11.18%
2010	NZ$0.02500	56%
2009	NZ$0.01603	249.11%
2008	NZ$0.004591

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)